The Voice of Epidemiology

    
    


    Web EpiMonitor

► Home ► About ► News ► Job Bank Events ► Resources ► Contact
 


Total Deaths In US Have Exceeded The Expected Level For 80 Consecutive Weeks

Excess Deaths Are Declining But Not Yet “Normal”

When will life return to the normal, prepandemic level of risk? This a question which has been on everyone’s mind during the COVID-19 pandemic. One possible measure to use in making this determination about normalcy is the weekly number of excess deaths obtained by comparing the observed number of deaths to the expected number based on an average number of deaths that occurred each week in the years before COVID-19. In theory, when the percentage of excess deaths (the number of excess deaths divided by the expected number)  falls to zero, then risk has returned to “normal” prepandemic levels.

Previous waves

In each of the three previous waves of COVID cases and deaths since early 2020, the numbers of weekly deaths have dropped from their peaks but remained well above the expected number, according to data maintained by  the Centers for Disease Control and Prevention. There has been an unbroken pattern of deaths above the expected average level for at least 80 consecutive weeks. At the time of the peak number of cases and deaths in the third wave in early January 2021, approximately one half of all deaths were excess deaths when compared to the average number in the years immediately before COVID.

Fourth wave

In the current fourth wave of the COVID-19 pandemic, the peak number of cases occurred in late August and early September 2021. According to CDC, the number of excess deaths has decreased from 71,828 for the week of September 4, 2021 to 61,188 for the week of October 2, 2021. (Table 1). The percent excess deaths has decreased from 37.8% to 14.5% over the same five week period. Data from more recent weeks in October are still incomplete as of this writing. While there are advantages to using excess deaths as a measure of the burden of mortality because it is not subject to the level of testing for for COVID-19, a disadvantage is the delay in the completeness of reporting.

Excess non-COVID deaths

Interestingly, the number of excess non-COVID-19 deaths not directly attributable to COVID has also been elevated above the expected number during parts of the earlier waves and during the fourth wave. However, these non-COVID deaths have now returned to the expected level and even below as of the week of October 2, 2021. (Table 2).

Significance

In media interviews, epidemiologists have expressed uncertainty about how low the current downward trend will go or if another wave will occur this winter. If deaths decline to expected levels, and remain that way for several weeks, this pattern could be interpreted as signaling a return to a normal level of prepandemic risk. However, because COVID-19 is a new cause of death, and may remain endemic even if not epidemic, baseline or expected levels of mortality risk may have to be revised upward. In short, returning to “normal” may require a new definition of normal.   ■


[Data below adapted from CDC]

TABLE 1 - Excess Deaths from all causes during COVID-19 pandemic

Week of

Expected

Observed

Excess

Percent Excess

Sept 4

52,111

71,828

19,717

37.8

Sept 11

52,453

71,291

18,838

35.9

Sept 18

52,800

70,215

17,515

33.0

Sept 25

52,869

66,794

13,925

26.3

Oct 2

53,459

61,188

  7,729

14.5

 

TABLE 2 - Excess Deaths from all causes excluding COVID-19 during COVID-19 pandemic

Week of

Expected

Observed

Excess

Percent Excess

Sept 4

52,111

56,170

   4,059

7.8

Sept 11

52,453

56,004

   3,551

6.8

Sept 18

52,800

55,379

   2,579

4.9

Sept 25

52,869

53,397

      528

1.0

Oct 2

53,459

50,303

(-3,156)

0.0

 

 

 

 

 

 

Reader Comments:
Have a thought or comment on this story ?  Fill out the information below and we'll post it on this page once it's been reviewed by our editors.
 

       
  Name:        Phone:   
  Email:         
  Comment: 
                 
 
       

           


 

 
 
 
      ©  2011 The Epidemiology Monitor

Privacy  Terms of Use  Sitemap

Digital Smart Tools, LLC